Greenwich LifeSciences, Inc.
NASDAQ:GLSIBiotechnology
-$0.74 today
- Market cap
- $302.08M
- Beta
- 1.38
- P/E (TTM)
- -15.6
- EPS (TTM)
- -$1.49
Volume 0.71M
Average 0.14M
GLSI Total Assets
Everything the company owns or controls; equal to total liabilities plus equity.
Greenwich LifeSciences, Inc.NASDAQ: GLSI
Total Assets · Q1 FY2026 · quarter ended Mar 2026
Total assets rises 281.9% from a year ago
Total assets stood at $10.51M at the end of Q1 FY2026, up 281.9% from a year earlier and up 255.9% from the prior quarter.
Context
- Total assets increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether total assets keeps rising in the next quarterly balance sheet after a +281.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Assets history
USD · from the balance sheet
- Latest · FY2025
- (6.74M) USD
- Year-over-year change
- -264.6%
| Period | Period end | Total Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (6.74M) | -264.6% |
| FY2024 | 2024-12-31 | 4.09M | -41.5% |
| FY2023 | 2023-12-31 | 6.99M | -48.1% |
| FY2022 | 2022-12-31 | 13.48M | -50.5% |
| FY2021 | 2021-12-31 | 27.22M | — |
Total Assets vs competitors
How GLSI compares with its peers on the latest reported figures
- Peers report in different currencies, so total assets is compared through growth and rates rather than absolute size.
- Its year-over-year change of +281.9% is the 2nd highest of 9, against a peer median of +21.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR |
|---|---|---|---|---|
| Mar 2026 | $272.13M USD | -21.6% | -15.3% | |
| Mar 2026 | $186.46M USD | -6.9% | -18.1% | |
| Mar 2026 | $120.71M USD | +5.1% | +3.3% | |
| Mar 2026 | $95.82M USD | +381.7% | +91.6% | |
IRDOpus Genetics, Inc. | Mar 2026 | $66.79M USD | +38.7% | +0.8% |
| Mar 2026 | $36.14M USD | +53.8% | -1.4% | |
| Mar 2026 | $29.7M USD | +102.9% | +21.6% | |
| Mar 2026 | $10.51M USD | +281.9% | — | |
| Mar 2026 | CA$8.16M CAD | -58.6% | -34.7% | |
| Peer median (excluding GLSI) | — | +21.9% | -0.3% | |
Competitors are the stored peer set for GLSI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Greenwich LifeSciences, Inc.
NASDAQ:GLSI
Intrinsic Alpha fair value
Locked
Current Price
$20.58
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.